Almost 80% of doctors in the United States have switched from paper to electronic health records.
There are multiple documentation strategies available for physicians to use to improve their interaction with patients and optimize their use of electronic health records.
Interoperability necessary to achieve the benefits of EHR infrastructure adoption.
The creation of this "big data system" continues, and promises to improve data quality and subsequently, patient outcomes.
Increased use of EHRs and other technology may mean less in-person visits and more "virtual" interactions between doctor and patient.
Advances are outpacing arrival speed for this potentially lifesaving technology.
A new survey reveals that oncologists greatly underestimate the rates of misdiagnosis in their field.
Farzad Mostashari urges physicians to redesign care flow to maximize productivity of EHRs
The U.S. Department of Health & Human Services has already met and exceeded its goal for 50% of physician offices and 80% of eligible hospitals to use EHR by end of 2013.
Since 2010, there has been a decrease in the satisfaction and usability ratings for certified electronic health records.
ASCO Debuts the CancerLINQ™ Prototype, a Knowledge-Sharing Network that May Revolutionize Cancer CareApril 05, 2013
A new database of patient information promises to change the way oncologists treat their patients in the future.
Screening colonoscopy is associated with a significant decrease in the risk of any colorectal cancer and of right colon cancer; and interventions using electronic health records increase screening rates.
Electronic health record use is linked to a lower rate of claims for physicians from multiple specialties.
The oncologist needs a full suite of features such as staging of tumors, data-intensive workflows, features for chemotherapy dosing and administration, assessment of toxicity, management of clinical trials, and tracking of drug inventories.
What are the best ways to combine good medical practice with good medico‑legal and legal practice in an era of 21st century cancer medicine?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Finding Clinical Trials in Cancer
- Adding Nintedanib Did Not Improve Survival in Lung Cancer Subtype
- The Identification of a Potential Early Plasma Biomarker for Kidney Cancer
- Pembrolizumab Plus Chemotherapy Extended Survival Longer Than Chemotherapy Alone: Study
- Combining Chemotherapy With Checkpoint Inhibitors Extends Overall Survival in ES-SCLC
- In a Head-to-Head Battle, Brigatinib Appears to Best Crizotinib